These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

240 related articles for article (PubMed ID: 34073721)

  • 1. 8a, a New Acridine Antiproliferative and Pro-Apoptotic Agent Targeting HDAC1/DNMT1.
    Zhang Q; Wang Z; Chen X; Qiu H; Gu Y; Wang N; Wang T; Wang Z; Ma H; Zhao Y; Zhang B
    Int J Mol Sci; 2021 May; 22(11):. PubMed ID: 34073721
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Molecular mechanisms underlying eicosapentaenoic acid inhibition of HDAC1 and DNMT expression and activity in carcinoma cells.
    Ceccarelli V; Ronchetti S; Marchetti MC; Calvitti M; Riccardi C; Grignani F; Vecchini A
    Biochim Biophys Acta Gene Regul Mech; 2020 Feb; 1863(2):194481. PubMed ID: 31923609
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Modulations of DNMT1 and HDAC1 are involved in the OTA-induced cytotoxicity and apoptosis in vitro.
    Zhou Y; Gan F; Hou L; Zhou X; Adam Ibrahim YA; Huang K
    Chem Biol Interact; 2017 Dec; 278():170-178. PubMed ID: 29080797
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Design, synthesis and anticancer potential of NSC-319745 hydroxamic acid derivatives as DNMT and HDAC inhibitors.
    Yuan Z; Sun Q; Li D; Miao S; Chen S; Song L; Gao C; Chen Y; Tan C; Jiang Y
    Eur J Med Chem; 2017 Jul; 134():281-292. PubMed ID: 28419930
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Development of a versatile DNMT and HDAC inhibitor C02S modulating multiple cancer hallmarks for breast cancer therapy.
    Yuan Z; Chen S; Gao C; Dai Q; Zhang C; Sun Q; Lin JS; Guo C; Chen Y; Jiang Y
    Bioorg Chem; 2019 Jun; 87():200-208. PubMed ID: 30901675
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Synergistic anti-cancer effects of epigenetic drugs on medulloblastoma cells.
    Yuan J; Llamas Luceño N; Sander B; Golas MM
    Cell Oncol (Dordr); 2017 Jun; 40(3):263-279. PubMed ID: 28429280
    [TBL] [Abstract][Full Text] [Related]  

  • 7. HDAC3 regulates DNMT1 expression in multiple myeloma: therapeutic implications.
    Harada T; Ohguchi H; Grondin Y; Kikuchi S; Sagawa M; Tai YT; Mazitschek R; Hideshima T; Anderson KC
    Leukemia; 2017 Dec; 31(12):2670-2677. PubMed ID: 28490812
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Class I HDACs are mediators of smoke carcinogen-induced stabilization of DNMT1 and serve as promising targets for chemoprevention of lung cancer.
    Brodie SA; Li G; El-Kommos A; Kang H; Ramalingam SS; Behera M; Gandhi K; Kowalski J; Sica GL; Khuri FR; Vertino PM; Brandes JC
    Cancer Prev Res (Phila); 2014 Mar; 7(3):351-61. PubMed ID: 24441677
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Development of a kind of RG108-Fluorescein conjugates for detection of DNA methyltransferase 1 (DNMT1) in living cells.
    Ruan M; Cheng Q; Gong C; Cao Z; Xu L; Zhang Q
    Anal Biochem; 2020 Oct; 607():113823. PubMed ID: 32758504
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Inhibition of HDAC1 and DNMT1 modulate RGS10 expression and decrease ovarian cancer chemoresistance.
    Cacan E; Ali MW; Boyd NH; Hooks SB; Greer SF
    PLoS One; 2014; 9(1):e87455. PubMed ID: 24475290
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Design and Synthesis of Novel Epigenetic Inhibitors Targeting Histone Deacetylases, DNA Methyltransferase 1, and Lysine Methyltransferase G9a with
    Rabal O; San José-Enériz E; Agirre X; Sánchez-Arias JA; de Miguel I; Ordoñez R; Garate L; Miranda E; Sáez E; Vilas-Zornoza A; Pineda-Lucena A; Estella A; Zhang F; Wu W; Xu M; Prosper F; Oyarzabal J
    J Med Chem; 2021 Mar; 64(6):3392-3426. PubMed ID: 33661013
    [TBL] [Abstract][Full Text] [Related]  

  • 12. DNA methyltransferase 1 knock down induces gene expression by a mechanism independent of DNA methylation and histone deacetylation.
    Milutinovic S; Brown SE; Zhuang Q; Szyf M
    J Biol Chem; 2004 Jul; 279(27):27915-27. PubMed ID: 15087453
    [TBL] [Abstract][Full Text] [Related]  

  • 13. (-)-Epigallocatechin-3-gallate reverses the expression of various tumor-suppressor genes by inhibiting DNA methyltransferases and histone deacetylases in human cervical cancer cells.
    Khan MA; Hussain A; Sundaram MK; Alalami U; Gunasekera D; Ramesh L; Hamza A; Quraishi U
    Oncol Rep; 2015 Apr; 33(4):1976-84. PubMed ID: 25682960
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Ginsenoside 20(s)-Rh2 as potent natural histone deacetylase inhibitors suppressing the growth of human leukemia cells.
    Liu ZH; Li J; Xia J; Jiang R; Zuo GW; Li XP; Chen Y; Xiong W; Chen DL
    Chem Biol Interact; 2015 Dec; 242():227-34. PubMed ID: 26482938
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Molecular mechanisms of transactivation and doxorubicin-mediated repression of survivin gene in cancer cells.
    Estève PO; Chin HG; Pradhan S
    J Biol Chem; 2007 Jan; 282(4):2615-25. PubMed ID: 17124180
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Selective Inhibitors of Histone Deacetylases 1 and 2 Synergize with Azacitidine in Acute Myeloid Leukemia.
    Min C; Moore N; Shearstone JR; Quayle SN; Huang P; van Duzer JH; Jarpe MB; Jones SS; Yang M
    PLoS One; 2017; 12(1):e0169128. PubMed ID: 28060870
    [TBL] [Abstract][Full Text] [Related]  

  • 17. tert-Butylcarbamate-containing histone deacetylase inhibitors: apoptosis induction, cytodifferentiation, and antiproliferative activities in cancer cells.
    Valente S; Trisciuoglio D; Tardugno M; Benedetti R; Labella D; Secci D; Mercurio C; Boggio R; Tomassi S; Di Maro S; Novellino E; Altucci L; Del Bufalo D; Mai A; Cosconati S
    ChemMedChem; 2013 May; 8(5):800-11. PubMed ID: 23526814
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Gallic acid, a phenolic acid, hinders the progression of prostate cancer by inhibition of histone deacetylase 1 and 2 expression.
    Jang YG; Ko EB; Choi KC
    J Nutr Biochem; 2020 Oct; 84():108444. PubMed ID: 32615369
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Selective inhibition of esophageal cancer cells by combination of HDAC inhibitors and Azacytidine.
    Ahrens TD; Timme S; Hoeppner J; Ostendorp J; Hembach S; Follo M; Hopt UT; Werner M; Busch H; Boerries M; Lassmann S
    Epigenetics; 2015; 10(5):431-45. PubMed ID: 25923331
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Inhibiting HDAC1 Enhances the Anti-Cancer Effects of Statins through Downregulation of GGTase-Iβ Expression.
    Li R; Gan YH
    Int J Mol Sci; 2017 May; 18(5):. PubMed ID: 28481295
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.